Gene mutation behind protein that helps regulate cholesterol levels identified

June 8, 2018 by Bob Yirka, Medical Xpress report
Space-filling model of the Cholesterol molecule. Credit: RedAndr/Wikipedia

A team of researchers affiliated with several institutions in China has identified a gene mutation that is at least partly responsible for regulating cholesterol levels in the bloodstream. In their paper published in the journal Science, the group describes how they tracked down the gene mutation responsible for the creation of a key protein involved in the process.

As the researchers note, (LDL-C) can build up in arteries, leading to heart attacks and strokes. For that reason, it would be helpful to know what causes it. Prior research has shown that genetics plays a factor in what happens to food containing LDL-C when it is consumed. But what genetic factors cause more of it to wind up in the arteries in some people and less in others? In this new effort, the researchers sought to learn more about such factors.

The study centered on analyzing the genes of a single family who all, save one, had abnormally low levels of LDL-C in their blood. The researchers were able to isolate a particular that differed for the one unique individual—a gene mutation called LIMA1. Pleased with their findings, the group then conducted genetic testing on 509 people from a group called the Chines Kazakh—they are known to have low levels of LDL-C in their blood. The initial family came from this group. Analysis of the data showed that those individuals with low levels of LDL-C in their blood also carried the same gene mutation, and those without it had normal levels. A closer look revealed that the gene mutation was responsible for the production of a protein, which they called LIMA1. That protein, the researchers surmised, was a regulator of LDL-C.

To learn more about LIMA1, the researchers conducted studies with mice and found that the protein appears to be expressed in the small intestine. They also suggest that the protein could be synthesized, possibly leading to new drugs to reduce in people—and hopefully to reduce the risk of developing cardiovascular disease.

Explore further: Inherited mutation leads to overproduction of EPO

More information: Ying-Yu Zhang et al. ALIMA1variant promotes low plasma LDL cholesterol and decreases intestinal cholesterol absorption, Science (2018). DOI: 10.1126/science.aao6575

A high concentration of low-density lipoprotein cholesterol (LDL-C) is a major risk factor for cardiovascular disease. Although LDL-C levels vary among humans and are heritable, the genetic factors affecting LDL-C are not fully characterized. We identified a rare frameshift variant in the LIMA1 (also known as EPLIN or SREBP3) gene from a Chinese family of Kazakh ethnicity with inherited low LDL-C and reduced cholesterol absorption. In a mouse model, LIMA1 was mainly expressed in the small intestine and localized on the brush border membrane. LIMA1 bridged NPC1L1, an essential protein for cholesterol absorption, to a transportation complex containing myosin Vb and facilitated cholesterol uptake. Similar to the human phenotype, Lima1-deficient mice displayed reduced cholesterol absorption and were resistant to diet-induced hypercholesterolemia. Through our study of both mice and humans, we identify LIMA1 as a key protein regulating intestinal cholesterol absorption.

Related Stories

Inherited mutation leads to overproduction of EPO

March 9, 2018
A newly discovered hereditary mutation is responsible for an increased production of erythropoietin (EPO) in the blood. This mutation causes a messenger RNA (mRNA) that is not normally involved in the formation of proteins ...

Mutation discovered to protect against Alzheimer's disease in mice

May 16, 2018
Researchers at the RIKEN Center for Brain Science have discovered a mutation that can protect against Alzheimer's disease in mice. Published in the scientific journal Nature Communications, the study found that a specific ...

Scientists discover how gene mutation reduces the need for sleep

March 19, 2018
It's every over-achiever's dream: a gene mutation that allows them to function normally with just four to six hours of sleep a night instead of the normal eight.

Gene mutation may speed up memory loss in Alzheimer's disease

May 3, 2017
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of ...

Common gene mutation bad for liver values, good for blood lipids in children

January 13, 2016
A common mutation in the TM6SF2 gene raises liver values but at the same time improves blood lipid values in healthy children, according to a recent study from the University of Eastern Finland. Children who carry the gene ...

Recommended for you

Researchers find potential new gene therapy for blinding disease

August 20, 2018
The last year has seen milestones in the gene therapy field, with FDA approvals to treat cancer and an inherited blinding disorder. New findings from a team led by University of Pennsylvania vision scientists, who have in ...

New study explains why genetic mutations cause disease in some people but not in others

August 20, 2018
Researchers at the New York Genome Center (NYGC) and Columbia University have uncovered a molecular mechanism behind one of biology's long-standing mysteries: why individuals carrying identical gene mutations for a disease ...

Critical role of DHA on foetal brain development revealed

August 17, 2018
Duke-NUS researchers have found evidence that a natural form of Docosahexaenoic Acid (DHA) made by the liver called Lyso-Phosphatidyl-Choline (LPC-DHA), is critical for normal foetal and infant brain development, and that ...

New algorithm could improve diagnosis of rare diseases

August 17, 2018
Today, diagnosing rare genetic diseases requires a slow process of educated guesswork. Gill Bejerano, Ph.D., associate professor of developmental biology and of computer science at Stanford, is working to speed it up.

Gene silencing critical for normal breast development

August 17, 2018
Researchers have discovered that normal breast development relies on a genetic 'brake', a protein complex that keeps swathes of genes silenced.

Officials remove special rules for gene therapy experiments

August 16, 2018
U.S. health officials are eliminating special regulations for gene therapy experiments, saying that what was once exotic science is quickly becoming an established form of medical care with no extraordinary risks.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.